Oxepinac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H12O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PF3750D8AE, chemically known as 6,11-dihydro-11-oxodibenz(b,e)oxepin-3-acetic acid but generally known as oxepinac, which bears US NIH Compound Identifier 41531. European Medicines Agency schedules Oxepinac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09515MIG. The term OXEPINAC is an International Non-Proprietary Name. OXEPINAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxepinac under HS 29329985 and SITC 51569. As of Q4 2014, OXEPINAC remains the US FDA Preferred Term for this commodity. Oxepinac bears US NLM identifiers UMLS ID C0069754 and NCI Concept Code C66260. SMILES: O1C2C(C(=O)C3C(C1)CCCC3)CCC(C2)CC(=O)O.